• Aucun résultat trouvé

Azidothymidine as a potential modifier of radiation-reponse

N/A
N/A
Protected

Academic year: 2021

Partager "Azidothymidine as a potential modifier of radiation-reponse"

Copied!
7
0
0

Texte intégral

(1)

PLEASE SCROLL DOWN FOR ARTICLE

This article was downloaded by: [University of Liege]

On: 5 March 2009

Access details: Access Details: [subscription number 787817762]

Publisher Informa Healthcare

Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House,

37-41 Mortimer Street, London W1T 3JH, UK

Acta Oncologica

Publication details, including instructions for authors and subscription information:

http://www.informaworld.com/smpp/title~content=t713690780

Azidothymidine (AZT) as a Potential Modifier of Radiation Response in Vitro

Marie-Laure Copaceanu a; Philippe A. Coucke a; Eliane Cottin a; Nicolas Paschoud b; Rene-Olivier Mirimanoff a

a Department of Radiation Oncology, Laboratory of Radiobiology, Lausanne, Switzerland b Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and Laboratory of Flow Cytometry, Clinique La Source, Lausanne, Switzerland

Online Publication Date: 01 January 1995

To cite this Article Copaceanu, Marie-Laure, Coucke, Philippe A., Cottin, Eliane, Paschoud, Nicolas and Mirimanoff, Rene-Olivier(1995)'Azidothymidine (AZT) as a Potential Modifier of Radiation Response in Vitro',Acta Oncologica,34:2,213 — 218 To link to this Article: DOI: 10.3109/02841869509093958

URL: http://dx.doi.org/10.3109/02841869509093958

Full terms and conditions of use: http://www.informaworld.com/terms-and-conditions-of-access.pdf

This article may be used for research, teaching and private study purposes. Any substantial or systematic reproduction, re-distribution, re-selling, loan or sub-licensing, systematic supply or distribution in any form to anyone is expressly forbidden.

The publisher does not give any warranty express or implied or make any representation that the contents will be complete or accurate or up to date. The accuracy of any instructions, formulae and drug doses should be independently verified with primary sources. The publisher shall not be liable for any loss, actions, claims, proceedings, demand or costs or damages whatsoever or howsoever caused arising directly or indirectly in connection with or arising out of the use of this material.

(2)
(3)
(4)
(5)
(6)
(7)

Références

Documents relatifs

Comme tout doit être fait avec une bénédic- tion, comme le dit le Saint Apôtre Pavel « que vous mangiez, que vous buviez, ou quoi que vous fassiez, c’est toujours à la gloire de

Maintenant, ça se fait plus trop de manger du mouton et de l’agneau, les gens ne mangent plus comme ça.. Chacun mange ce

Multiple epidemiological gene association studies have detected a link between a single nucleotide polymorphism in the human connexin37 (Cx37) gene and coronary artery disease

Key Words FGF21 • Leptin • Insulin resistance • Obesity Abstract Background/Aims: Fibroblast growth factor 21 FGF21, a potent metabolic regulator, has been shown to improve

It was found that the optimized nano-oil could reduce the coefficient of friction and increase wear resistance, as compared with conventional diesel engine oil.. Some adhesive

niques (dissociations auprès de patients cérébro-lésés, pré- sentation tachistoscopique chez le sujet sain, imagerie par résonance magnétique fonctionnelle) convergent vers

La norme IFRS 13 – Evaluation à la juste valeur, appliquée pour la première fois en 2013 sur les actifs et passifs, n’a pas eu d’impact significatif sur la juste valeur

”La Cathédrale protestante, Tobias Stimmer et l’horloge astronomique” dans Christian Grappe (dir.) La Cathédrale de Strasbourg en sa ville.. Le spirituel et